You are here

  • Home
  • Archive
  • Volume 72, Issue 4
  • HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

Authors

  1. Correspondence to Michael T Nurmohamed, Department of Rheumatology and Internal Medicine, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands; mt.nurmohamed{at}vumc.nl
View Full Text

Citation

Raterman HG, Levels H, Voskuyl AE, et al
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab
Annals of the Rheumatic Diseases 2013;72:560-565.

Publication history

  • Accepted April 9, 2012
  • First published May 15, 2012.
Online issue publication 
August 10, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions